PTC299 Recruiting Phase 1 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03761069Study of PTC299 in Relapsed/Refractory Acute Leukemias